Picture of Calliditas Therapeutics AB logo

CALT Calliditas Therapeutics AB News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMid CapMomentum Trap

U.S. STOCKS ON THE MOVE-CarMax, Spotify, Immunovant

* 
      Eikon search string for individual stock moves:  STXBZ 
    

        * 
      The Day Ahead newsletter: https://refini.tv/3LI4BU7
    

        * 
      The Morning News Call newsletter: https://refini.tv/3dKUyB8
    

  
U.S. stocks were set for a higher open on Thursday, recovering from a broad
sell-off on Wall Street in the prior session as investors clung to hopes of
borrowing costs easing next year, while chipmaker Micron advanced after
delivering an upbeat forecast.  .N 
    
    At 9:05 ET, Dow e-minis  1YMc1  were up 0.57% at 37,659. S&P 500 e-minis
 ESc1  were up 0.73% at 4,784.25, while Nasdaq 100 e-minis  NQc1  were up 1.00%
at 16,933.25.
 
 The top two NYSE percentage gainers premarket  .PRPG.NQ :
 ** Terran Orbital Corporation  LLAP.K , up 16.2%
 ** European Equity Fund  EEA , up 10.5%
 
 The top three NYSE percentage losers premarket  .PRPL.NQ :
 ** Envestnet Inc  ENV , down 26.9%
 ** ServisFirst Bancshares Inc SFBS.K , down 22.2%
 ** Enova International  ENVA.K , down 22.1%
 
 The top two Nasdaq percentage gainers premarket  .PRPG.O :
 ** Smart For Life Inc  SMFL.O , up 235.2%
 ** Infrared Cameras Holdings Inc  MSAI.O , up 128.2%
 
 The top three Nasdaq percentage losers premarket  .PRPL.O :
 ** Cytek Biosciences Inc  CTKB.O , down 41.4%
 ** Clene Inc.  CLNN.O , down 32.1%
 ** PRA Group Inc  PRAA.O , down 31.7%
 
 
 ** BlackBerry Ltd  BB.N : down 4.4% premarket
 BUZZ - ADRs slide as Q4 revenue forecast falls below estimates  urn:newsml:reuters.com:*:nL4N3DG246 

 ** Micron Technology Inc  MU.O : up 7.3% premarket
 BUZZ - Jumps after results, forecast top expectations  urn:newsml:reuters.com:*:nL4N3DG22H 
    
 ** Boeing Co  BA.N : up 1.7% premarket
 BUZZ - Up on report China to approve first 787 delivery since April 2021
 urn:newsml:reuters.com:*:nL4N3DG2AQ 
    
 ** Calliditas Therapeutics AB  CALT.O : up 15.7% premarket
 BUZZ - Surges on US FDA's approval for kidney disease drug  urn:newsml:reuters.com:*:nL4N3DG2C7
    
 ** CarMax Inc  KMX.N : up 10.2% premarket
 BUZZ - Rises on higher Q3 profit  urn:newsml:reuters.com:*:nL4N3DG2H8
    
 ** Spotify Technology SA  SPOT.N : up 2.6% premarket
 BUZZ - Pivotal says Spotify appears to have won audio-streaming war, raises to
'buy' urn:newsml:reuters.com:*:nL4N3DG2EJ
    
 ** Clene Inc  CLNN.O : down 32.1% premarket
 BUZZ - Down after FDA says ALS drug data insufficient for accelerated
approval urn:newsml:reuters.com:*:nL4N3DG2JP
    
 ** Immunovant Inc  IMVT.O : up 14.5% premarket
 BUZZ - Rises as autoimmune drug succeeds in mid-stage trial  urn:newsml:reuters.com:*:nL4N3DG2HF
    
 ** Albemarle Corporation  ALB.N : up 1.9% premarket
 BUZZ - Gains after Citi raises PT  urn:newsml:reuters.com:*:nL4N3DG2G6
    
 ** Newmont Corporation  NEM.N : up 1.7% premarket
 BUZZ - Gold miners gain as focus turns to US economic data  urn:newsml:reuters.com:*:nL4N3DG2L4
    
 ** Warner Bros. Discovery Inc  WBD.O : up 1.2% premarket
 BUZZ - Warner Bros Discovery, Paramount potential deal beset with hurdles -
brokerage  urn:newsml:reuters.com:*:nL4N3DG29E
    
 **  Hookipa Pharma  HOOK.O : up 82.3% premarket
 BUZZ - Rises as Gilead builds stake  urn:newsml:reuters.com:*:nL4N3DG2NU
    
 ** Sellas Life Sciences Group  SLS.O : up 3.3% premarket
 BUZZ - Rises on FDA's 'orphan' tag for blood cancer drug  urn:newsml:reuters.com:*:nL4N3DG2PG
    
 ** Salesforce Inc  CRM.N : up 1.4% premarket
 BUZZ - Rises as Morgan Stanley upgrades, hikes PT to Street-high  urn:newsml:reuters.com:*:nL4N3DG2OS
    
 ** Energy Fuels  UUUU.A : up 2.0% premarket
 BUZZ - Rises on starting uranium production in Arizona and Utah  urn:newsml:reuters.com:*:nL4N3DG2P7
    
 ** Triumph Group Inc  TGI.N : up 8.4% premarket
 BUZZ - Rises on sale of Product Support unit  urn:newsml:reuters.com:*:nL4N3DG2PL

 (Compiled by Sneha S K)
 ((Sneha.sk@thomsonreuters.com))

Recent news on Calliditas Therapeutics AB

See all news